Home » Stocks » VRPX

Virpax Pharmaceuticals, Inc. (VRPX)

Virpax Pharmaceuticals will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00 - $12.00
Current IPO price range
Market Cap 49.60M
Revenue (ttm) n/a
Net Income (ttm) -3.66M
Shares Out 4.51M
EPS (ttm) -0.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Hide News
TheStreet - 1 month ago

West Chester, Pennsylvania-based Virpax was founded to create new formulations for the use of existing, approved drugs for various forms of pain management applications.

SEC - 3 months ago

Virpax Pharmaceuticals, Inc. has filed to go public with an IPO on the NASDAQ stock exchange.

About VRPX

Virpax Pharmaceuticals is a preclinical stage biopharmaceutical company focused on becoming a global leader in pain management by developing and delivering innovative non-opioid and non-addictive pharmaceutical products using new drug delivery systems and technology. We are developing branded pharmaceutical product candidates for pain management by using advanced technology in an effort to enhance patients’ quality of life. We have exclusive global rights to develop, sell and export (among other rights) a proprietary patented nonsteroid anti-... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
Pending
CEO
Anthony Mack
Employees
2
Stock Exchange
NASDAQ
Ticker Symbol
VRPX
Full Company Profile